NASDAQ$MEDP

Medpace Holdings Inc. · Q1 2020 earnings

Q1 2020 earnings · · Investor relations

Briefing

Reported first quarter results with revenue increase and net new business awards.

Medpace Holdings, Inc. announced financial results for the first quarter ended March 31, 2020. Revenue increased by 15.0% to $230.9 million compared to the prior-year period. GAAP net income was $29.0 million, or $0.76 per diluted share, versus GAAP net income of $19.2 million, or $0.51 per diluted share, for the first quarter of 2019.

  • Revenue of $230.9 million increased 15.0% from the prior-year period.
  • Net new business awards were $246.9 million.
  • GAAP net income was $29.0 million, or $0.76 per diluted share.
  • EBITDA was $40.6 million.

Headline financials

Total Revenue

$231M

Previous: $201M+15.0%
EPS (adj)

$0.76

Previous: $0.64+18.8%
Net New Business Awards

$247M

Previous: $249M-0.7%
Capital Expenditures

-$5.56M

Previous: -$2.52M-120.7%
Free Cash Flow

$23.4M

Previous: $16.7M+40.3%
Net Income

$29M

Previous: $19.2M+50.8%
Operating Income

$35.5M

Previous: $25.9M+37.1%
Gross Profit

-$166M

Previous: -$146M-13.8%
Cash & Equivalents

$134M

Previous: $30.1M+344.8%
Total Assets

$1.14B

Previous: $1.01B+13.0%
Stock-Based Comp

$5.45M

Previous: $3.18M+71.1%

Revenue & EPS history

Medpace · Revenue · Quarterly

$231M

Q1 2020+15%vs Q1 2019
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Forward guidance

Due to economic uncertainty, the Company is withdrawing previously provided revenue, EBITDA, net income, and net income per diluted share guidance and is not issuing new guidance at this time.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2020

Historical avgQ1 2020

-1.7%

Avg return

Earnings day

-1.6%

Avg return

5 days after

+1.1%

Avg return

30 days after

44%

19 / 43 earnings

Positive

+39.0%

Q3 2022

Best reaction

-31.5%

Q1 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.5%-19.4%-14.9%
Q4 2025-15.9%-19.3%-16.3%
Q3 2025+9.0%+6.2%+8.2%
Q2 2025-0.2%+1.5%+7.0%
Q1 2025-2.3%+3.3%+1.4%
Q4 2024-7.5%-4.0%-10.3%
Q3 2024-8.4%-7.3%-8.5%
Q2 2024-15.2%-9.5%-6.1%
Q1 2024+9.4%+6.4%+4.8%
Q4 2023+11.6%+20.0%+25.0%
Q3 2023+18.8%+9.2%+20.8%
Q2 2023+4.6%+3.9%+1.8%
Q1 2023+10.2%+5.9%+7.2%
Q4 2022-2.9%-7.6%-20.4%
Q3 2022+39.0%+41.5%+39.2%
Q2 2022-2.9%+5.0%+3.8%
Q1 2022-12.0%-11.3%-12.2%
Q4 2021-20.6%-18.2%-12.1%
Q3 2021+13.9%+21.1%+14.4%
Q2 2021-6.0%-3.4%-0.8%
Q1 2021-12.8%-11.3%-13.3%
Q4 2020-2.7%-5.3%-2.0%
Q3 2020-6.1%-4.8%+4.4%
Q2 2020+15.5%+12.8%+16.7%
Q1 2020-2.5%-11.9%+9.0%
Q4 2019+2.4%-9.7%-31.7%
Q3 2019+0.8%-0.5%+3.8%
Q2 2019+24.9%+19.9%+27.2%
Q1 2019-4.3%-1.6%-4.7%
Q4 2018-21.3%-21.8%-18.4%
Q3 2018+0.2%+13.9%+21.8%
Q2 2018+28.6%+24.4%+23.4%
Q1 2018+2.3%-0.0%+12.9%
Q4 2017-15.7%-14.3%-5.3%
Q3 2017+6.2%+5.6%-3.7%
Q2 2017+8.0%+15.1%+17.2%
Q1 2016-31.5%-29.1%-12.6%
Q1 2017-29.1%-27.5%-12.3%
Q4 2014-21.3%-20.7%-22.2%
Q2 2016-21.3%-20.7%-22.2%
Q4 2016-19.8%-20.1%-22.3%
Q3 2016+3.8%+8.1%+24.0%
Q4 2015+3.8%+8.1%+24.0%
Q3 2015
Q2 2015
Q1 2015
Q1 2014

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro